Telaprevir
VX11-950-114
Phase 3 small_molecule terminated
Quick answer
Telaprevir for Hepatitis C, Chronic is a Phase 3 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Hepatitis C, Chronic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated